A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel Disease

Clinical trial NCT07229950 · RECRUITING

Trial details

NCT number: NCT07229950
Sponsor: Shandong Suncadia Medicine Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Patients With Moderately to Severely Active Ulcerative Colitis

Start date: 2025-10-17
Primary completion: 2026-12-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.